<DOC>
	<DOCNO>NCT01308125</DOCNO>
	<brief_summary>Pressure intermittent coronary sinus occlusion ( PICSO ) patient coronary artery disease improve collateral flow index high 30 % . PICSO use patient population safe , feasible effective . Safety , feasibility effectiveness test periprocedural logistic data .</brief_summary>
	<brief_title>Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion ( PICSO ) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention</brief_title>
	<detailed_description>1 Background Good collateral flow case obstructive coronary artery disease acute myocardial beneficial effect morbidity mortality . Pressure control Intermittent Coronary Sinus Occlusion ( PICSO ) carry promise improve myocardial flow , decrease microvascular obstruction decrease rate peri-procedural acute myocardial infarction without increase risk bleeding encounter gp2b3a inhibitor . This study design evaluate safety feasibility PICSO patient stable coronary artery disease experimental short coronary artery occlusion . 2 . Objective The purpose study determine whether PICSO safe feasible femoral approach , amount case PICSO effective increase collateral flow index ( CFI ) . In study adapt collateral flow pressure index ( CFpI ) use calculate ratio distal LAD pressure LAD balloon occlusion ( PLADoccl . ) Aortic pressure ( Pao ) . CFI &gt; 30 % show several study significant predictor inducible ischemia measure intracoronary ST-segment change . The study non-randomized single centre trial use Bayesian statistical model . 3 . Specific This study study 10 elective patient coronary artery disease assess safety feasibility adjunctive PICSO treatment PCI use femoral vein approach . Together preclinical experience use Miracor technology , therefore believe plan cohort 10 patient sufficient corroborate earlier experience safety procedure well present technology . For effectiveness , 10 set measurement procedure patient provide insight clinical significance since patient serve control . Study end-points 3.1 Primary endpoint 1 . Duration successful femoral vein cannulation successful placement PICSO Impulse catheter Coronary Sinus . 2 . Relative increase collateral flow pressure index ( CFpI ) LAD occlusion without PICSO . 3.2 Secondary endpoint 1 . Number patient reach collateral flow pressure index ( CFpI ) high 30 % PICSO . 2 . Quantitative evaluation pre-condition effect relative increase CFpI . 3 . The change ST segment record Intra coronary ECG measure balloon inflation . 3.3 Primary safety endpoint 1 . The patient hemodynamic stable PICSO . 2 . Elevation coronary sinus pressure 3 . The 30 day MACE comparable patient undergo PCI . 1 . Stroke 2 . Bleeding 3 . Inflammation 4 . New onset acute coronary syndrome newly document heart failure , require therapy hospitalization 5 . Pulmonary embolism 6 . Coronary sinus permanent occlusion 7 . Death 8 . Other Adverse Events 4 . No reported Adverse Events cause PICSO</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>Subjects ( men woman ) least 18 year age Coronary artery disease assess angiography Clinical indication PCI Able understand content willing provide write informed consent Active treat malignancy within 12 month prior Visit 1 Anatomical complication ( e.g . The system able effectively occlude coronary sinus ) Presence significant colleteral flow supply target vessel ( Rentrop &gt; 1 ) Any significant systemic illness medical condition could lead difficulty comply protocol ; concurrent condition ( ) , investigator 's opinion , would prohibit subject complete study , would best interest subject Bleeding perforation PCI , pericardial effusion and/or hematoma Cardiac arrest arrhythmia require chest compression cardiopulmonary resuscitation Cardiogenic shock ( Cardiac Index &lt; 1.8 L/min/metersquared assess investigator ) , pulmonary edema ( Killip Class &gt; 2 ) , hemodynamic instability assess investigator time cardiac catheterization Clinically significant renal disturbance ( sMDRD calculate GFRâ‰¤30 mL/min/1,73m2 ) Coronary Sinus electrode place Acute ST elevation myocardial infarction Previous Qwave myocardial infarction target area History acute myocardial infarction within 72h prior screen Ejection fraction &lt; 20 % History stroke , sequelae transient ischemic attack ( TIA ) , reversible ischemic neurological defect ( RIND ) within 6 month prior screen Left Bundle Branch Block Mitral regurgitation ( MR ) &gt; grade I Mitral stenosis . Patient currently sinus rhythm Patients cardiac resynchronization therapy ( CRT ) schedule CRT implantation Patients previous CABG plan chronic total occlusion revascularization Pregnancy active breastfeeding . Urine pregnancy test perform woman postmenopausal least 1 year Registration another interventional study Severe anemia baseline ( Hemoglobin &lt; 10 g/dl &lt; 6.2 mmol/l )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Stable Angina</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>PCI</keyword>
	<keyword>Reperfusion</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>collateral flow pressure index</keyword>
	<keyword>CFpI</keyword>
	<keyword>pressure control intermittent coronary sinus occlusion</keyword>
	<keyword>PICSO</keyword>
</DOC>